Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Key cardiovascular gene therapy patent awarded to CardioGene Therapeutics

Oct. 8, 1997

Hoechst describes Na+/H+-exchange inhibitors for ischemic disorders

Oct. 8, 1997

New discovery enhances feasibility of cardiovascular gene therapy

Oct. 8, 1997

FDA approves irbesartan for marketing

Oct. 8, 1997

Millennium and Lilly extend cardiovascular research collaboration

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Cytokine synthesis inhibitor protects against polymicrobial sepsis in animal model

Oct. 6, 1997

Novel class III antiarrhythmic agents described by Merck & Co.

Oct. 6, 1997

Cypros to start phase III trial for CABG

Oct. 3, 1997

Focus on benzoyl guanidines as Na+/H+-exchange inhibitors

Oct. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.